Biotech · Public company · Cupertino, CA, US
Reviva Pharmaceuticals Holdings, Inc.
Ticker RVPH · SEC CIK 0001742927
Track this companyFree. Adds Reviva Pharmaceuticals Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- BrilaroxazinePhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- aripiprazolePhase 2 · Acute SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- RP5063Phase 2 · Acute SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaPHASE3 · RECRUITING · started Jan 24, 2022ClinicalTrials.gov NCT05184335 · fetched Nov 12, 2026
- RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderPHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01490086 · fetched Nov 12, 2026
SEC filings12
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 23, 2025 · fetched Nov 12, 2026